Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Journal of Immunology (Baltimore, Md. : 1950)|May 17, 2016
Privileged Antigen Presentation in Splenic B Cell Follicles Maximizes T Cell Responses in Prime-Boost VaccinationByram W Bridle, Andrew Nguyen, Omar Salem, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 18, 2010
Synergistic interaction between oncolytic viruses augments tumor killingFabrice Le Boeuf, Jean-Simon Diallo, J Andrea McCart, et al.
Viruses|February 27, 2020
Measles Vaccines Designed for Enhanced CD8<sup>+</sup> T Cell ActivationElena Busch, Kristina D Kubon, Johanna K M Mayer, et al.
Cancer Immunology Research|December 8, 2025
A universal boosting strategy for adoptive T cell therapy using a paired vaccine/chimeric antigen receptorRebecca Burchett, Claire G Morris, Mira Ishak, et al.
Cancer Cell|October 31, 2003
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agentsDavid F Stojdl, Brian D Lichty, Benjamin R tenOever, et al.
Oncolytic Virotherapy|December 13, 2018
Development and applications of oncolytic Maraba virus vaccinesJonathan G Pol, Matthew J Atherton, Byram W Bridle, et al.
Cancer Immunology Research|September 16, 2017
Customized Viral Immunotherapy for HPV-Associated CancerMatthew J Atherton, Kyle B Stephenson, Jonathan Pol, et al.
Pageof 8